StonvexLoading…
StonvexStonvexStonvexCore line items from MASS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $56.20M | $47.75M | $50.23M | $46.85M |
Operating Income | $-39.42M | $-57.39M | $-42.76M | $-35.38M |
Net Income | $19.49M | $-72.21M | $-36.40M | $-33.56M |
EPS (Diluted) | $0.54 | $-2.12 | $-1.13 | $-1.07 |
Total Assets | $190.07M | $159.48M | $202.98M | $242.59M |
Total Liabilities | $46.37M | $44.88M | $37.49M | $51.99M |
Cash & Equivalents | $70.52M | $44.03M | $121.04M | $188.42M |
Free Cash Flow OCF − CapEx | $-24.64M | $-30.85M | $-27.10M | $-22.98M |
Shares Outstanding | 36.32M | 35.10M | 32.52M | 31.86M |